Skip to main content
Article
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children with Nephrotic Syndrome
Kidney International Reports (2019)
  • Debbie S. Gipson, University of Michigan
  • Howard Trachtman, New York University
  • Anne Waldo, University of Michigan
  • Keisha L. Gibson, University of North Carolina at Chapel Hill
  • Sean Eddy, University of Michigan
  • Katherine M. Dell, Case Western Reserve University
  • Tarak Srivastava, University of Missouri–Kansas City
  • Kevin V. Lemley, Boston Children's Hospital
  • Larry A. Greenbaum, Emory University
  • Sangeeta Hingorani, University of Washington
  • Kevin E. Meyers, Children's Hospital of Philadelphia
  • Frederick J. Kaskel, Albert Einstein College of Medicine
  • Kimberly J. Reidy, Albert Einstein College of Medicine
  • Christine B. Sethna, Cohen Children's Medical Center of New York, New Hyde Park, NY
  • Cheryl L. Tran, Mayo Clinic
  • Chia-shi Wang, Emory University
  • Katherine R. Tuttle, University of Washington
  • Gia Oh, Stanford University
  • Alicia M. Neu, Johns Hopkins University School of Medicine
  • Elizabeth Brown, University of Texas Southwestern Medical Center
  • Jen-Jar Lin, Wake Forest University
  • Jennifer Lai Yee, University of Michigan
  • Therese M. Roth, University of Michigan
  • Jonathan P. Troost, University of Michigan
  • Brenda W. Gillespie, University of Michigan
  • Matthew G. Sampson, Boston Children's Hospital
  • Matthias Kretzler, University of Michigan
  • Wenjun Ju, University of Michigan
Publication Date
December 1, 2019
DOI
10.1016/j.ekir.2019.11.018
Citation Information
Debbie S. Gipson, Howard Trachtman, Anne Waldo, Keisha L. Gibson, et al.. "Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children with Nephrotic Syndrome" Kidney International Reports (2019)
Available at: http://works.bepress.com/katherine-tuttle/214/